Xiangxue Pharmaceutical Co (SZSE:300147) 3-Year EBITDA Growth Rate : -35.60% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co 3-Year EBITDA Growth Rate?

Xiangxue Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was -35.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Xiangxue Pharmaceutical Co was 35.80% per year. The lowest was -35.60% per year. And the median was 13.70% per year.

Competitive Comparison of Xiangxue Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Xiangxue Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xiangxue Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiangxue Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Xiangxue Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Xiangxue Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Xiangxue Pharmaceutical Co (SZSE:300147) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Xiangxue Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co (SZSE:300147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co (SZSE:300147) Headlines

No Headlines